Use of a simplified local guideline improves “front door” management of diabetes and hyperglycaemia in people admitted to hospital with COVID-19
DOI:
https://doi.org/10.15277/bjd.2022.397Keywords:
COVID-19, diabetes, hyperglycaemia, guideline, local, national, dexamethasone, audit, compliance, standardsReferences
Dexamethasone in Hospitalized People with Covid-19. The RECOVERY Collaborative Group. N Engl J Med 2021;384:693-704. https://doi.org/10.1056/NEJMoa2021436
Mendes TB, Câmara-de-Souza AB, Halpern B. Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations. Diabetol Metab Syndr 2022;14:37. https://doi.org/10.1186/s13098-022-00808-x
Concise advice on Inpatient Diabetes (COVID:Diabetes) Guidelines. National inpatient diabetes COVID-19 response group. Version 1.4 29/6/2020. https://www.diabetes.org.uk/resources-s3/public/2020-08/NEW%20-%20COvID_Dex_v1.4.pdf
Williamson EJ, Walker AJ, Bhaskaran A, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584(7821): 430-36. https://doi.org/10.1038/s41586-020-2521-4
Hayek S, Ben-Shlomo Y, Balicer R, et al. Preinfection glycaemic control and disease severity among people with type 2 diabetes and COVID-19: A retrospective, cohort study. Diabetes Obes Metab 2021;23(8):1-6. (https://doi.org/10.1111/dom.14393)
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.